Ubs Group Ag 10x Genomics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 244,754 shares of TXG stock, worth $3.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244,754

Previous 151,557 61.49%

Holding current value

$3.87 Million

Previous $2.95 Million 87.51%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $1.46 Million - $2.19 Million	93,197 Added 61.49%	244,754 $5.53 Million
Q2 2024 Aug 13, 2024	BUY	$19.45 - $37.37 $1.89 Million - $3.64 Million	97,290 Added 179.28%	151,557 $2.95 Million
Q1 2024 May 13, 2024	BUY	$36.08 - $54.3 $1.73 Million - $2.61 Million	48,038 Added 771.2%	54,267 $2.04 Million
Q4 2023 Feb 09, 2024	SELL	$34.32 - $57.55 $167,550 - $280,959	-4,882 Reduced 43.94%	6,229 $348,000
Q3 2023 Nov 09, 2023	BUY	$40.86 - $62.98 $50,176 - $77,339	1,228 Added 12.43%	11,111 $458,000
Q2 2023 Aug 11, 2023	SELL	$50.96 - $58.72 $641,535 - $739,226	-12,589 Reduced 56.02%	9,883 $551,000
Q1 2023 May 12, 2023	BUY	$35.33 - $55.79 $620,924 - $980,509	17,575 Added 358.89%	22,472 $1.25 Million
Q4 2022 Feb 08, 2023	BUY	$24.4 - $41.3 $73,907 - $125,097	3,029 Added 162.15%	4,897 $178,000
Q3 2022 Nov 10, 2022	SELL	$28.48 - $52.59 $30,331 - $56,008	-1,065 Reduced 36.31%	1,868 $53,000
Q2 2022 Aug 10, 2022	SELL	$36.95 - $82.41 $776,245 - $1.73 Million	-21,008 Reduced 87.75%	2,933 $132,000
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $398,255 - $1.04 Million	-7,150 Reduced 23.0%	23,941 $1.82 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $276,717 - $374,126	2,049 Added 7.06%	31,091 $4.63 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $617,987 - $815,634	4,245 Added 17.12%	29,042 $4.23 Million
Q2 2021 Aug 13, 2021	SELL	$134.22 - $202.37 $742,236 - $1.12 Million	-5,530 Reduced 18.23%	24,797 $4.86 Million
Q1 2021 May 12, 2021	SELL	$140.25 - $196.86 $861,836 - $1.21 Million	-6,145 Reduced 16.85%	30,327 $5.49 Million
Q4 2020 Feb 11, 2021	SELL	$126.47 - $163.7 $3.54 Million - $4.58 Million	-27,980 Reduced 43.41%	36,472 $5.17 Million
Q3 2020 Nov 12, 2020	BUY	$87.44 - $125.0 $2.66 Million - $3.81 Million	30,471 Added 89.67%	64,452 $8.04 Million
Q2 2020 Jul 31, 2020	BUY	$58.39 - $89.31 $328,268 - $502,100	5,622 Added 19.82%	33,981 $3.04 Million
Q1 2020 May 01, 2020	BUY	$51.57 - $106.62 $214,531 - $443,539	4,160 Added 17.19%	28,359 $1.77 Million
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $1.07 Million - $1.84 Million	23,162 Added 2233.56%	24,199 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $51,839 - $64,294	1,037 New	1,037 $52,000

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account